Wharton School professor Jeremy Siegel on Friday issued a strong warning about President Donald Trump's sweeping tariff ...

Buying $100 In CBOE: If an investor had bought $100 of CBOE stock 10 years ago, it would be worth $395.04 today based on a price of $223.47 for CBOE at the time of writing.

Karman announced the acquisition of Metal Technology Inc., a specialist in refractory metal products for missile programs, ...

Buying $100 In BURL: If an investor had bought $100 of BURL stock 10 years ago, it would be worth $399.59 today based on a ...

Wedbush tech analyst Dan Ives on Friday morning described Trump's tariffs as a "bad science experiment that in the process ...

Today, Benzinga 's options scanner spotted 50 uncommon options trades for Palantir Technologies. This isn't normal. The ...

Looking at options history for APA APA we detected 9 trades. If we consider the specifics of each trade, it is accurate to ...

Vimeo launches Vimeo Streaming, a creator-first platform for building subscription-based streaming services with no coding required. Packed with AI-powered tools, custom apps, and global reach, it ...

Buying $100 In CVNA: If an investor had bought $100 of CVNA stock 5 years ago, it would be worth $293.96 today based on a ...

Applied Mat has a lower P/E than the aggregate P/E of 45.97 of the Semiconductors & Semiconductor Equipment industry. Ideally ...

FTAI Aviation FTAI -11.2% Get Free Report has outperformed the market over the past 5 years by 48.91% on an annualized basis ...

The FDA approved Amgen's Uplizna as the first treatment for IgG4-RD. The decision is backed by the MITIGATE trial, showing reduced flares and sustained efficacy.